According to MRI-based data, the highest dose of the drug displayed signs of reduced number of lesions in the study, but improvements as reported by patients or doctors were not yet seen at the end of the 12-month treatment period, Recursion said.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/azO79VH
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment